Home / Germany / AnaptysBio, Inc.
AnaptysBio, Inc.
Short position disclosed on February 7, 2018.
0.59% of the capital sold short
1 disclosing funds
3 disclosures on record
US0327241065 ISIN code
Funds holding AnaptysBio, Inc. Titelia
Evolution of the disclosed total
0%0.2%0.4%0.6%
Oct 2025Jan 2026Apr 2026Jul 2026
January 24, 2018 today
Open positions
| Fund | Twelve months | % of capital | Over the year | Since |
|---|---|---|---|---|
| PDT Partners, LLC | 0.59% | unchanged | February 7, 2018 |
History of disclosures
| Date | Fund | % of capital | End of publication |
|---|---|---|---|
| February 7, 2018 | PDT Partners, LLC | 0.59% | still open |
| January 25, 2018 | PDT Partners, LLC | 0.68% | still open |
| January 24, 2018 | PDT Partners, LLC | 0.70% | still open |
Other companies sold short in Germany
- TUI AG 9.00% of the capital sold short
- AUTO1 Group SE 7.29% of the capital sold short
- HelloFresh SE 7.00% of the capital sold short
- Hugo Boss AG 6.18% of the capital sold short
- Gerresheimer AG 5.98% of the capital sold short
- Cancom SE 5.46% of the capital sold short
- PVA TePla AG 5.30% of the capital sold short
- Zalando SE 5.22% of the capital sold short
- LANXESS Aktiengesellschaft 5.11% of the capital sold short
- Tamboran Resources Corp. 4.96% of the capital sold short
- Kontron AG 4.94% of the capital sold short
- Aeluma, INC. 4.82% of the capital sold short
Cite this page
The figure comes from the regulator register, not from this site. Quoting both lets your reader check it.
QuiVad, AnaptysBio, Inc., source Bundesanzeiger, data as at February 7, 2018, https://www.quivad.com/action/anaptysbio-inc